AstraZeneca boosts oncology portfolio in Japan with Daiichi denosumab deal
24 May 2011
Pial Ganguli
Please Login to read the full article.
24 May 2011
Pial Ganguli
Please Login to read the full article.
RELATED CONTENT
NEWS
- Denosumab launched in first indications in Japan through Daiichi Sankyo
- Denosumab filed for large but competitive osteoporosis indication in Japan
- AVEO's unconvincing Phase II ficlatuzumab data point to need for further studies
- New Japanese approvals include Xarelto for stroke prevention
ANALYSIS
Other Informa Analysis
EVENTS
Today
Le Plaza Hotel, Brussels, Belgium
Today
Diplomat Hotel, Prague, Czech Republic
Today
Business Design Centre, London
JOB OF THE WEEK
Section Head (m/f)
DRA International/CIS Section
Section Head (m/f)
DRA International/CIS Section
